| 07/05/2024 |
Oncopeptides AB |
Stig Anders Jacob Lindberg |
Other senior executive |
|
Subscription |
Oncopeptides AB BTA |
BTA |
SE0021924370 |
03/05/2024 |
1,090,708 |
Quantity |
2.60 |
SEK |
|
Notification
|
| 06/05/2024 |
Oncopeptides AB |
Per Wold-Olsen |
Chairman of the Board of Directors |
|
Subscription |
Oncopeptides BTA |
BTA |
SE0021924370 |
03/05/2024 |
519,180 |
Quantity |
2.60 |
SEK |
|
Notification
|
| 06/05/2024 |
Oncopeptides AB |
Sofia Heigis |
Chief Executive Officer (CEO)/Managing Directory |
|
Subscription |
Oncopeptides AB BTA |
BTA |
SE0021924370 |
03/05/2024 |
66,804 |
Quantity |
2.60 |
SEK |
History |
Notification
|
| 06/05/2024 |
Oncopeptides AB |
David Augustsson |
Other member of the company's administrative, management or supervisory body |
|
Subscription |
Oncopeptides BTA |
BTA |
SE0021924370 |
03/05/2024 |
9,332 |
Quantity |
2.60 |
SEK |
|
Notification
|
| 06/05/2024 |
Oncopeptides AB |
Henrik Bergentoft |
Chief Financial Officer (CFO) |
|
Subscription |
Oncopeptides BTA |
BTA |
SE0021924370 |
03/05/2024 |
13,332 |
Quantity |
2.60 |
SEK |
|
Notification
|
| 04/05/2024 |
Oncopeptides AB |
Sofia Heigis |
Chief Executive Officer (CEO)/Managing Directory |
|
Acquisition |
Oncopeptides AB BTA |
BTA |
SE0021924370 |
03/05/2024 |
66,804 |
Quantity |
2.60 |
SEK |
Revised |
Notification
|
| 03/05/2024 |
Oncopeptides AB (publ) |
Cecilia Daun Wennborg |
Member of the Board of Directors |
|
Subscription |
Oncopeptides AB BTA |
BTA |
SE0021924370 |
03/05/2024 |
15,732 |
Quantity |
2.60 |
SEK |
|
Notification
|
| 03/05/2024 |
Oncopeptides AB |
Stefan Norin |
Other member of the company's administrative, management or supervisory body |
|
Subscription |
Oncopeptides AB BTA |
BTA |
SE0021924370 |
03/05/2024 |
2,664 |
Quantity |
2.60 |
SEK |
|
Notification
|
| 03/05/2024 |
Oncopeptides AB (publ.) |
Eva Sabina Marianne Nordström |
Deputy CEO/Deputy Managing Director |
|
Subscription |
Oncopeptides AB BTA |
BTA |
SE0021924370 |
03/05/2024 |
160,264 |
Quantity |
2.60 |
SEK |
|
Notification
|
| 29/04/2024 |
Oncopeptides AB |
Sofia Heigis |
Chief Executive Officer (CEO)/Managing Directory |
|
Acquisition |
Oncopeptides AB TR |
Subscription right/Unit right |
SE0021924362 |
29/04/2024 |
30,000 |
Quantity |
0.0366 |
SEK |
History |
Notification
|